RELX PLC (REN.AS)
- Previous Close
38.50 - Open
38.50 - Bid --
- Ask --
- Day's Range
38.14 - 38.54 - 52 Week Range
27.45 - 41.31 - Volume
179,172 - Avg. Volume
689,765 - Market Cap (intraday)
72.47B - Beta (5Y Monthly) 0.46
- PE Ratio (TTM)
35.08 - EPS (TTM)
1.09 - Earnings Date --
- Forward Dividend & Yield 0.69 (1.79%)
- Ex-Dividend Date May 2, 2024
- 1y Target Est
19.65
RELX PLC, together with its subsidiaries, provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Risk; Scientific, Technical & Medical; Legal; and Exhibitions. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk. The Scientific, Technical & Medical segment provides information and data sets that help researchers and healthcare professionals to advance science and health outcomes. The Legal segment provides legal, regulatory, and business information and analytics that help customers in decision-making, as well as increases the productivity. The Exhibitions segment is involved in the business that combines face-to-face with data and digital tools to help customers learn about markets, source products, and complete transactions. The company was formerly known as Reed Elsevier PLC and changed its name to RELX PLC in July 2015. RELX PLC was incorporated in 1903 and is headquartered in London, the United Kingdom.
www.relx.com34,675
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: REN.AS
Performance Overview: REN.AS
Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: REN.AS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: REN.AS
Valuation Measures
Market Cap
71.94B
Enterprise Value
79.32B
Trailing P/E
35.17
Forward P/E
27.10
PEG Ratio (5yr expected)
3.60
Price/Sales (ttm)
6.87
Price/Book (mrq)
17.89
Enterprise Value/Revenue
8.66
Enterprise Value/EBITDA
23.95
Financial Highlights
Profitability and Income Statement
Profit Margin
19.44%
Return on Assets (ttm)
10.71%
Return on Equity (ttm)
49.72%
Revenue (ttm)
9.16B
Net Income Avi to Common (ttm)
1.78B
Diluted EPS (ttm)
1.09
Balance Sheet and Cash Flow
Total Cash (mrq)
155M
Total Debt/Equity (mrq)
188.92%
Levered Free Cash Flow (ttm)
1.71B
Research Analysis: REN.AS
Company Insights: REN.AS
REN.AS does not have Company Insights